inTEST (INTT) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue reached a record $34.0 million, up 4% year-over-year and 14% sequentially, driven by the Alfamation acquisition, which contributed $9.7 million.
Gross margin declined to 40.6%, primarily due to lower volume, unfavorable product mix, and reduced high-margin semiconductor sales.
Net earnings for Q2 2024 were $230,000 ($0.02 per diluted share), down sharply from the prior year, with adjusted net earnings of $1.0 million ($0.08 per diluted share) and adjusted EBITDA of $2.2 million (6.3% margin).
The Alfamation acquisition expanded presence in auto/EV and life sciences, offsetting ongoing semiconductor market weakness and achieving a record quarter for that business.
Orders improved 15% sequentially but declined year-over-year, with backlog at $47.7 million, about 50% expected to ship beyond Q3.
Financial highlights
Q2 revenue increased $1.4 million year-over-year, with auto/EV and industrial markets growing, mainly from the Alfamation acquisition, offsetting an $8.7 million decline in semi.
Gross margin contracted 325–560 basis points sequentially and year-over-year due to product mix and lower high-margin semi sales.
Operating expenses increased $1.8 million year-over-year, mainly from the acquisition, but legacy business OPEX was reduced by nearly $1 million sequentially.
Free cash outflow was $5.4 million; cash and equivalents ended at $20.4 million, down from $45.3 million at year-end 2023, mainly due to the acquisition.
Total debt at quarter end was $21.1 million, up due to acquisition-related borrowings.
Outlook and guidance
Q3 2024 revenue expected to be slightly lower than Q2, with some gross margin improvement; operating expenses and EPS expected to be similar to Q2.
2024 revenue guidance updated to $128–133 million (down from $140–150 million); gross margin expected at 42–43%; operating expenses around $53–54 million.
Effective tax rate expected at 17–19%; capital expenditures to run 1–2% of sales.
Demand for front-end semi solutions expected to remain subdued into 2025.
Backlog supports revenue visibility for the next twelve months.
Latest events from inTEST
- Q4 momentum in diversified markets and record backlog set up double-digit growth for 2026.INTT
Q4 202527 Feb 2026 - Vision 2030 targets $235–$285M revenue by 2030 through innovation, M&A, and operational excellence.INTT
Investor Day 20253 Feb 2026 - Vision 2030 targets $235–$285M revenue via innovation, acquisitions, and global expansion.INTT
17th Annual Southwest IDEAS Conference3 Feb 2026 - Record Q2 revenue driven by acquisitions, but margins and guidance impacted by market softness.INTT
15th Annual Midwest IDEAS Investor Conference22 Jan 2026 - Diversification and acquisitions drive growth amid semi market softness and evolving demand.INTT
IAccess Alpha Buyside Best Ideas Virtual Fall Conference20 Jan 2026 - Q3 2024 gross margin rose to 46.3% as Alfamation and diversified markets offset semi weakness.INTT
Q3 202417 Jan 2026 - Growth strategy and acquisitions drive margin gains, backlog growth, and a strong outlook for 2024.INTT
2024 Southwest IDEAS Conference13 Jan 2026 - Strategic transformation and acquisitions fuel growth, margin gains, and a strong outlook.INTT
27th Annual Needham Growth Conference10 Jan 2026 - Record revenue in 2024; 2025 outlook cautious amid market and tariff uncertainty.INTT
Q4 202426 Dec 2025